论文部分内容阅读
设计并合成了９个目标化合物，其中７个化合物未见文献报道。初步体外药理实验结果表明，化合物（Ⅱｂ）对花生四烯酸和骨胶原诱导的兔血小板聚集模型有良好的抑制活性，其活性与阳性对照药阿司匹林相平行。
Nine target compounds were designed and synthesized, of which seven compounds were not reported in the literature. Preliminary pharmacological experiments in vitro showed that compound (Ⅱb) had good inhibitory activity against arachidonic acid and collagen induced rabbit platelet aggregation model, and its activity was in parallel with positive control aspirin.